StemCell Institute Inc. (TYO:7096)
829.00
-4.00 (-0.48%)
Jan 13, 2026, 2:47 PM JST
StemCell Institute Market Cap
StemCell Institute has a market cap or net worth of 8.49 billion as of January 13, 2026. Its market cap has decreased by -35.84% in one year.
Market Cap
8.49B
Enterprise Value
6.29B
Revenue
2.72B
Ranking
n/a
PE Ratio
42.63
Stock Price
829.00
Market Cap Chart
Since June 25, 2021, StemCell Institute's market cap has decreased from 21.16B to 8.49B, a decrease of -59.85%. That is a compound annual growth rate of -18.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2026 | 8.49B | 4.54% |
| Dec 30, 2025 | 8.13B | -38.48% |
| Dec 30, 2024 | 13.21B | -39.88% |
| Dec 29, 2023 | 21.97B | -17.47% |
| Dec 30, 2022 | 26.62B | 9.16% |
| Dec 30, 2021 | 24.39B | 15.25% |
| Jun 25, 2021 | 21.16B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 13.86T |
| HOYA Corporation | 8.38T |
| Takeda Pharmaceutical Company | 7.93T |
| Daiichi Sankyo Company | 6.55T |
| Otsuka Holdings | 4.80T |
| Astellas Pharma | 4.01T |
| Terumo | 3.35T |
| Shionogi & | 2.46T |